The Rising Concern Over Hepatotoxic Botanicals: What You Need to Know

In the United States, herbal and dietary supplements (HDS) have grown exponentially. These supplements, often marketed as natural remedies to boost health and treat various ailments, have become a staple in many households. However, a recent study published in JAMA Network Open has shed light on a lesser-known risk associated with some of these supplements—potential liver toxicity or hepatotoxicity.

The Study in Focus

The study titled “Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults,” conducted by Dr Alisa Likhitsup and her colleagues, analyzed data from the National Health and Nutrition Examination Survey (NHANES) to assess the prevalence of six botanicals commonly associated with liver damage. These botanicals are turmeric, green tea extract, Garcinia cambogia, black cohosh, red yeast rice, and ashwagandha. The findings were eye-opening: approximately 4.7% of US adults, or about 15.6 million people, reported using at least one of these potentially hepatotoxic botanicals in the past 30 days.

The Popularity of Hepatotoxic Botanicals

Among the six botanicals studied, turmeric was the most frequently used, followed by green tea extract, ashwagandha, Garcinia cambogia, red yeast rice, and black cohosh. These supplements are widely consumed for various reasons, such as improving joint health, boosting energy, aiding weight loss, and managing menopause symptoms.

Despite their popularity, the study highlights a significant concern: most users of these botanicals were unaware of the potential risks associated with their consumption. The vast majority were taking these supplements without any recommendation from healthcare providers, relying instead on marketing claims and popular belief in the health benefits of these “natural” products.

The Hidden Dangers

Hepatotoxicity refers to liver damage caused by chemical substances. While the liver is a resilient organ, capable of regenerating itself after injury, repeated or severe damage can lead to serious conditions such as hepatitis, cirrhosis, or even liver failure. The study’s authors emphasized that the risk of liver damage from these botanicals is not negligible, particularly given the lack of regulatory oversight in the manufacturing and testing of these products.

For instance, turmeric and green tea extract, while generally considered safe in dietary amounts, have been associated with liver injury in some cases when taken in concentrated forms. Garcinia cambogia, often promoted as a weight loss supplement, has been linked to acute liver failure. Black cohosh, used by women to manage menopausal symptoms, has also been implicated in cases of liver toxicity.

Who Is at Risk?

The study found that users of these potentially hepatotoxic botanicals tend to be older, more educated, and more likely to have chronic conditions such as arthritis. Interestingly, these users were also more likely to take prescription medications, which raises concerns about potential interactions between botanicals and drugs, further complicating liver health.

Moreover, the study revealed that many individuals were consuming multiple HDS products simultaneously, which could increase the risk of adverse effects. For example, users of red yeast rice and ashwagandha were found to consume a median of four different supplements, raising questions about the cumulative impact of these products on liver health.

The Regulatory Gap

One of the key takeaways from the study is the glaring lack of regulatory oversight in the HDS industry. Unlike prescription medications, which undergo rigorous testing for safety and efficacy, dietary supplements are not subject to the same level of scrutiny by the Food and Drug Administration (FDA). This means that the actual contents of these products can vary significantly from what is listed on the label, and their potential effects on the liver are not always well understood.

The study’s authors called for increased regulatory oversight, including mandatory safety testing of HDS products and accurate ingredient labeling. They also urged healthcare providers to take a proactive role in educating patients about the potential risks associated with these supplements, particularly those with known hepatotoxic effects.

What Should Consumers Do?

If you are among the millions of Americans who take herbal supplements, it is important to be aware of the potential risks. Here are a few steps you can take to protect your liver health:

  1. Consult Your Healthcare Provider: Before starting any new supplement, especially if you are taking prescription medications or have a chronic health condition, talk to your healthcare provider. They can help you assess the potential risks and benefits based on your health needs.
  2. Research the Supplement: Look for reliable information on the safety and efficacy of the supplement you are considering. Be wary of marketing claims that sound too good to be true, and seek out scientific studies or reviews from reputable sources.
  3. Watch for Signs of Liver Trouble: If you experience symptoms such as jaundice (yellowing of the skin or eyes), dark urine, fatigue, or unexplained nausea, stop taking the supplement and seek medical attention immediately. These could be signs of liver damage.
  4. Limit the Use of Multiple Supplements: Taking several supplements simultaneously can increase the risk of interactions and adverse effects. Stick to a few well-researched products that address your specific health needs.

Conclusion

The use of herbal and dietary supplements is widespread, and many people assume that because these products are “natural,” they are also safe. However, as the study by Dr. Likhitsup and colleagues illustrates, this is not always the case. Certain botanicals can pose a real risk to liver health, particularly when taken in concentrated forms or in combination with other supplements and medications.

As consumers, it is crucial to approach these products cautiously and seek guidance from healthcare professionals. At the same time, there is a pressing need for more robust regulation and oversight of the HDS industry to ensure these products are safe and accurately labelled. Only then can consumers make truly informed decisions about their health.

1.

American Medical Association. Dietary supplements: underregulated, unknown, and maybe unsafe. Accessed January 19, 2024. https://www.ama-assn.org/delivering-care/public-health/dietary-supplements-underregulated-unknown-and-maybe-unsafe

2.

Mishra  S, Stierman  B, Gahche  JJ, Potischman  N.  Dietary Supplement Use Among Adults: United States, 2017–2018. NCHS Data Brief, No. 399. National Center for Health Statistics; 2021.

3.

Navarro  V, Avula  B, Khan  I,  et al.  The contents of herbal and dietary supplements implicated in liver injury in the United States are frequently mislabeled.   Hepatol Commun. 2019;3(6):792-794. doi:10.1002/hep4.1346PubMedGoogle ScholarCrossref

4.

Avigan  MI, Mozersky  RP, Seeff  LB.  Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States.   Int J Mol Sci. 2016;17(3):331. doi:10.3390/ijms17030331PubMedGoogle ScholarCrossref

5.

Fontana  RJ, Watkins  PB, Bonkovsky  HL,  et al; DILIN Study Group.  Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.   Drug Saf. 2009;32(1):55-68. doi:10.2165/00002018-200932010-00005PubMedGoogle ScholarCrossref

6.

Navarro  VJ, Khan  I, Björnsson  E, Seeff  LB, Serrano  J, Hoofnagle  JH.  Liver injury from herbal and dietary supplements.   Hepatology. 2017;65(1):363-373. doi:10.1002/hep.28813PubMedGoogle ScholarCrossref

7.

Pierard  S, Coche  JC, Lanthier  P,  et al.  Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution.   Eur J Gastroenterol Hepatol. 2009;21(8):941-945. doi:10.1097/MEG.0b013e3283155451PubMedGoogle ScholarCrossref

8.

Navarro  VJ, Bonkovsky  HL, Hwang  SI, Vega  M, Barnhart  H, Serrano  J.  Catechins in dietary supplements and hepatotoxicity.   Dig Dis Sci. 2013;58(9):2682-2690. doi:10.1007/s10620-013-2687-9PubMedGoogle ScholarCrossref

9.

Zheng  EX, Rossi  S, Fontana  RJ,  et al.  Risk of liver injury associated with green tea extract in SLIMQUICK weight loss products: results from the DILIN prospective study.   Drug Saf. 2016;39(8):749-754. doi:10.1007/s40264-016-0428-7PubMedGoogle ScholarCrossref

10.

Hoofnagle  JH, Bonkovsky  HL, Phillips  EJ,  et al; Drug-Induced Liver Injury Network.  HLA-Bb35:01 and green tea-induced liver injury.   Hepatology. 2021;73(6):2484-2493. doi:10.1002/hep.31538PubMedGoogle ScholarCrossref

11.

Vuppalanchi  R, Bonkovsky  HL, Ahmad  J,  et al; Drug-Induced Liver Injury Network.  Garcinia cambogia, either alone or in combination with green tea, causes moderate to severe liver injury.   Clin Gastroenterol Hepatol. 2022;20(6):e1416-e1425. doi:10.1016/j.cgh.2021.08.015PubMedGoogle ScholarCrossref

12.

Philips  CA, Valsan  A, Theruvath  AH,  et al; Liver Research Club India.  Ashwagandha-induced liver injury: a case series from India and literature review.   Hepatol Commun. 2023;7(10):e0270. doi:10.1097/HC9.0000000000000270PubMedGoogle ScholarCrossref

13.

Halegoua-DeMarzio  D, Navarro  V, Ahmad  J,  et al.  Liver injury associated with turmeric-a growing problem: ten cases from the Drug-Induced Liver Injury Network [DILIN].   Am J Med. 2023;136(2):200-206. doi:10.1016/j.amjmed.2022.09.026PubMedGoogle ScholarCrossref

14.

Hillman  L, Gottfried  M, Whitsett  M,  et al.  Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury.   Am J Gastroenterol. 2016;111(7):958-965. doi:10.1038/ajg.2016.114PubMedGoogle ScholarCrossref

15.

National Institutes of Health Office of Dietary Supplements. Dietary Supplement Label Database (DSLD). Accessed July 1, 2023. https://dsld.od.nih.gov/

16.

Zipf  G, Chiappa  M, Porter  KS, Ostchega  Y, Lewis  BG, Dostal  J. National Health and Nutrition Examination Survey: plan and operations, 1999-2010.  Vital Health Stat 1. 2013;(56):1-37.

17.

Stierman  B, Afful  J, Carroll  MD,  et al.  National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files—Development of Files and Prevalence Estimates for Selected Health Outcomes. National Health Statistics Reports; No. 158. National Center for Health Statistics; 2021.

18.

Centers for Disease Control and Prevention. NHANES 2017-March 2020 pre-pandemic. Accessed July 1, 2023. https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?Cycle=2017-2020

19.

Centers for Disease Control and Prevention. NHANES 1999-2020 data documentation, codebook, and frequencies. Accessed July 1, 2023. https://wwwn.cdc.gov/nchs/nhanes/1999-2000/DSII.htm#Analytic_Notes

20.

Friedrich-Rust  M, Ong  MF, Martens  S,  et al.  Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.   Gastroenterology. 2008;134(4):960-974. doi:10.1053/j.gastro.2008.01.034PubMedGoogle ScholarCrossref

21.

United States Census Bureau. 2020 U.S. Census results. Accessed July 1, 2023. https://www.census.gov/programs-surveys/decennial-census/decade/2020/2020-census-results.html

22.

ClinCalc.com. The top 300 of 2021 provided by the ClinCalc Drugstats Database. Accessed December 1, 2023. https://clincalc.com/DrugStats/Top300Drugs.aspx

23.

National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: clinical and research information on drug-induced liver injury, 2012-. Updated June 20, 2024. Accessed January 19, 2024. https://www.ncbi.nlm.nih.gov/books/NBK547852/

24.

American Association for Public Opinion Research. Best practices for survey research. Accessed May 22, 2024. https://aapor.org/standards-and-ethics/best-practices

25.

US Food and Drug Administration.  Dietary Supplement Health and Education Act of 1994; Public Law 103–417. US Food and Drug Administration; 1994.

26.

Gahche  JJ, Bailey  RL, Potischman  N,  et al.  Federal monitoring of dietary supplement use in the resident, civilian, noninstitutionalized US population, National Health and Nutrition Examination Survey.   J Nutr. 2018;148(suppl 2):1436S-1444S. doi:10.1093/jn/nxy093PubMedGoogle ScholarCrossref

27.

Council for Responsible Nutrition. The science behind the supplements: economic impact of the dietary supplement industry. Accessed January 31, 2024. https://www.crnusa.org/resources/economic-impact-dietary-supplement-industry#:~:text=In%20the%20United%20States%2C%20the,for%20health%20and%20wellness%20products

28.

Farina  EK, Austin  KG, Lieberman  HR.  Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions.   J Acad Nutr Diet. 2014;114(11):1784-90.e2. doi:10.1016/j.jand.2014.01.016PubMedGoogle ScholarCrossref

29.

Du  M, Luo  H, Blumberg  JB,  et al.  Dietary supplement use among adult cancer survivors in the United States.   J Nutr. 2020;150(6):1499-1508. doi:10.1093/jn/nxaa040PubMedGoogle ScholarCrossref

30.

Geller  AI, Shehab  N, Weidle  NJ,  et al.  Emergency department visits for adverse events related to dietary supplements.   N Engl J Med. 2015;373(16):1531-1540. doi:10.1056/NEJMsa1504267PubMedGoogle ScholarCrossref

31.

Estes  JD, Stolpman  D, Olyaei  A,  et al.  High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.   Arch Surg. 2003;138(8):852-858. doi:10.1001/archsurg.138.8.852
ArticlePubMedGoogle ScholarCrossref

32.

Chalasani  N, Fontana  RJ, Bonkovsky  HL,  et al; Drug Induced Liver Injury Network (DILIN).  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.   Gastroenterology. 2008;135(6):1924-1934, 1934.e1-1934.e4. doi:10.1053/j.gastro.2008.09.011PubMedGoogle ScholarCrossref

33.

García-Cortés  M, Borraz  Y, Lucena  MI,  et al.  Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry  [in Spanish].  Rev Esp Enferm Dig. 2008;100(11):688-695. doi:10.4321/s1130-01082008001100004PubMedGoogle ScholarCrossref

34.

Centers for Disease Control and Prevention (CDC).  Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building—May-October 2013.   MMWR Morb Mortal Wkly Rep. 2013;62(40):817-819.PubMedGoogle Scholar

35.

Bonkovsky  HL, Kleiner  DE, Gu  J,  et al; U.S. Drug Induced Liver Injury Network Investigators.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.   Hepatology. 2017;65(4):1267-1277. doi:10.1002/hep.28967PubMedGoogle ScholarCrossref

36.

Koenig  G, Callipari  C, Smereck  JA.  Acute liver injury after long-term herbal “liver cleansing” and “sleep aid” supplement use.   J Emerg Med. 2021;60(5):610-614. doi:10.1016/j.jemermed.2021.01.004PubMedGoogle ScholarCrossref

37.

Kesar  V, Channen  L, Masood  U,  et al.  Liver transplantation for acute liver injury in Asians is more likely due to herbal and dietary supplements.   Liver Transpl. 2022;28(2):188-199. doi:10.1002/lt.26260PubMedGoogle ScholarCrossref

38.

Satia-Abouta  J, Kristal  AR, Patterson  RE, Littman  AJ, Stratton  KL, White  E.  Dietary supplement use and medical conditions: the VITAL study.   Am J Prev Med. 2003;24(1):43-51. doi:10.1016/S0749-3797(02)00571-8PubMedGoogle ScholarCrossref

39.

Mah  E, Chen  O, Liska  DJ, Blumberg  JB.  Dietary supplements for weight management: a narrative review of safety and metabolic health benefits.   Nutrients. 2022;14(9):1787. doi:10.3390/nu14091787PubMedGoogle ScholarCrossref

40.

O’Connor  EA, Evans  CV, Ivlev  I,  et al.  Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. 2022;327(23):2334-2347. doi:10.1001/jama.2021.15650
ArticlePubMedGoogle ScholarCrossref

41.

Mangione  CM, Barry  MJ, Nicholson  WK,  et al; US Preventive Services Task Force.  Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement.   JAMA. 2022;327(23):2326-2333. doi:10.1001/jama.2022.8970
ArticlePubMedGoogle ScholarCrossref

42.

Radimer  K, Bindewald  B, Hughes  J, Ervin  B, Swanson  C, Picciano  MF.  Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.   Am J Epidemiol. 2004;160(4):339-349. doi:10.1093/aje/kwh207PubMedGoogle ScholarCrossref

43.

Rock  CL.  Multivitamin-multimineral supplements: who uses them?   Am J Clin Nutr. 2007;85(1):277S-279S. doi:10.1093/ajcn/85.1.277SPubMedGoogle ScholarCrossref

44.

Patterson  RE, Neuhouser  ML, Hedderson  MM, Schwartz  SM, Standish  LJ, Bowen  DJ.  Changes in diet, physical activity, and supplement use among adults diagnosed with cancer.   J Am Diet Assoc. 2003;103(3):323-328.PubMedGoogle Scholar

45.

Miller  MF, Bellizzi  KM, Sufian  M, Ambs  AH, Goldstein  MS, Ballard-Barbash  R.  Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study.   J Am Diet Assoc. 2008;108(3):483-494. doi:10.1016/j.jada.2007.12.005PubMedGoogle ScholarCrossref

46.

Abdel-Rahman  O.  Dietary supplements use among adults with cancer in the United States: a population-based study.   Nutr Cancer. 2021;73(10):1856-1863. doi:10.1080/01635581.2020.1820050PubMedGoogle ScholarCrossref

47.

Barrett  LA, Xing  A, Sheffler  J,  et al.  Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey.   PLoS One. 2022;17(6):e0269241. doi:10.1371/journal.pone.0269241PubMedGoogle ScholarCrossref

48.

Hewlings  SJ, Kalman  DS.  Curcumin: a review of its effects on human health.   Foods. 2017;6(10):92. doi:10.3390/foods6100092PubMedGoogle ScholarCrossref

49.

Zeng  L, Yang  T, Yang  K,  et al.  Efficacy and safety of curcumin and Curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial.   Front Immunol. 2022;13:891822. doi:10.3389/fimmu.2022.891822PubMedGoogle ScholarCrossref

50.

Hursel  R, Viechtbauer  W, Dulloo  AG,  et al.  The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis.   Obes Rev. 2011;12(7):e573-e581. doi:10.1111/j.1467-789X.2011.00862.xPubMedGoogle ScholarCrossref

51.

Rondanelli  M, Riva  A, Petrangolini  G,  et al.  Effect of acute and chronic dietary supplementation with green tea catechins on resting metabolic rate, energy expenditure and respiratory quotient: a systematic review.   Nutrients. 2021;13(2):644. doi:10.3390/nu13020644PubMedGoogle ScholarCrossref

52.

Akbarialiabad  H, Dahroud  MD, Khazaei  MM, Razmeh  S, Zarshenas  MM.  Green tea, a medicinal food with promising neurological benefits.   Curr Neuropharmacol. 2021;19(3):349-359. doi:10.2174/1570159X18666200529152625PubMedGoogle ScholarCrossref

53.

Mena-García  A, Bellaizac-Riascos  AJ, Rada-Mendoza  M, Chito-Trujillo  DM, Ruiz-Matute  AI, Sanz  ML.  Quality Evaluation of dietary supplements for weight loss based on Garcinia cambogia.   Nutrients. 2022;14(15):3077. doi:10.3390/nu14153077PubMedGoogle ScholarCrossref

54.

US Food and Drug Administration. Dietary supplements. Accessed January 1, 2024. https://www.fda.gov/food/dietary-supplements

55.

US Food and Drug Administration. FDA’s regulation of dietary supplements with Dr. Cara Welch: Q&A with FDA podcast/transcript. Accessed January 1, 2024. https://www.fda.gov/drugs/news-events-human-drugs/fdas-regulation-dietary-supplements-dr-cara-welch

56.

Nahin  RL, Pecha  M, Welmerink  DB, Sink  K, DeKosky  ST, Fitzpatrick  AL; Ginkgo Evaluation of Memory Study Investigators.  Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people.   J Am Geriatr Soc. 2009;57(7):1197-1205. doi:10.1111/j.1532-5415.2009.02329.xPubMedGoogle ScholarCrossref